10x Genomics (TXG) President & CSO Benjamin J. Hindson Sells Shares

What Happened

• Benjamin J. Hindson, President and Chief Scientific Officer of 10x Genomics (TXG), sold 13,818 shares in an open-market transaction on August 24, 2026. The weighted average sale price reported was $63.02, for total proceeds of approximately $870,860. This transaction is a sale (not a buy) and was executed to satisfy tax withholding obligations related to the vesting of restricted stock units (RSUs).

Key Details

• Transaction date: 2026-08-24 (filed 2026-08-26) — appears to be filed within the typical 2 business-day window.
• Transaction type/code: Sale (S); reason footnote: tax withholding for RSU vesting (F1/F2).
• Shares sold: 13,818; weighted average price: $63.02; total proceeds ≈ $870,860.
• Price range: trades executed at prices between $63.0088 and $63.78; reported price is the weighted average (reporting person will provide per-trade breakdown on request).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• No 10b5‑1 plan or other trading plan was indicated in the excerpt.

Context

• The filing indicates this was a routine sell-to-cover for tax withholding on vested RSUs. Such transactions are common for executives receiving equity compensation and do not, by themselves, necessarily signal a change in the insider’s view of the company.
• No options were exercised and no new awards were reported in this transaction.